Referencias:

• Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., Protein tyrosine phosphatases in the human genome (2004) Cell, 117, pp. 699-711
• Andersen, J.N., Jansen, P.G., Echwald, S.M., Mortensen, O.H., Fukada, T., Del Vecchio, R., A genomic perspective on protein tyrosine phosphatases: Gene structure, pseudogenes, and genetic disease linkage (2004) FASEB J, 18, pp. 8-30
• Arcasoy, M.O., The non-haematopoietic biological effects of erythropoietin (2008) Br J Haematol, 141, pp. 14-31
• Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor (2004) Proc Natl Acad Sci USA, 101 (4912), pp. 14907-14911
• Buckley, D.A., Cheng, A., Kiely, P.A., Tremblay, M.L., O'Connor, R., Regulation of insulin-like growth factor type i (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGFI-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts (2002) Mol Cell Biol, 22, pp. 1998-2010
• Callero, M., Vota, D.M., Chamorro, M.E., Wenker, S.D., Vittori, D.C., Nesse, A.B., Calcium as a mediator between erythropoietin and protein tyrosine phosphatase 1B (2011) Arch Biochem Biophys, 505, pp. 242-249
• Callero, M., Pérez, G.M., Vittori, D.C., Vota, D.M., Pregi, N., Nesse, A.B., Modulation of protein tyrosine phosphatase 1B by erythropoietin in UT-7 cell line (2007) Cell Physiol Biochem, 20, pp. 319-328
• Chamorro, M.E., Wenker, S.D., Vota, D.M., Vittori, D.C., Nesse, A.B., Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative (2013) Biochim Biophys Acta, 1833, pp. 1960-1968
• Coleman, T., Westenfelder, C., Togel, F., Yang, Y., Hu, Z., Swenson, L.A., Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities (2006) Proc Natl Acad Sci USA, 103, pp. 5965-5970
• Dube, N., Tremblay, M.L., Beyond the metabolic function of PTP1B (2004) Cell Cycle, 3, pp. 550-553
• Fantacci, M., Bianciardi, P., Caretti, A., Coleman, T.R., Cerami, A., Brines, M., Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia (2006) Proc Natl Acad Sci USA, 103, pp. 17531-17534
• Gu, F., Dube, N., Kim, J.W., Cheng, A., Ibarra-Sánchez, M., De, J., Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling (2003) Mol Cell Biol, 23, pp. 3753-3762
• Habeeb, A.F., Determination of free amino groups in proteins by trinitrobenzenesulfonic acid (1966) Anal Biochem, 14, pp. 328-336
• Haj, G., Markova, B., Klaman, L.D., Bohmer, F.D., Neel, B.G., Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B (2003) J Biol Chem, 278, pp. 739-744
• Kenner, K.A., Anyanwu, E., Olefsky, J.M., Kusari, J., Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling (1996) J Biol Chem, 271, pp. 19810-19816
• Laemmli, U.K., Clivage of structural protein during the assembly for the head of bacteriphage T4 (1970) Nature, 227, pp. 680-685
• Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Derivatives of Erythropoietin that are tissue protective but not erythropoietic (2004) Science, 305, pp. 239-242
• Mulcahy, L., The erythropoietin receptor (2001) Semin Oncol, 20, pp. 19-23
• Myers, M.P., Andersen, J.N., Cheng, A., Tremblay, M.L., Horvath, C.M., Parisien, J.P., TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B (2001) J Biol Chem, 276, pp. 47771-47774
• Nakao, T., Geddis, A., Fox, N., Kaushansky, K., PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27kip1 (2008) Cell Cycle, 7, pp. 257-266
• Pregi, N., Vittori, D., Pérez, G., Pérez Leirós, C., Nesse, A., Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells (2006) Biochim Biophys Acta, 1763, pp. 238-246
• Ramirez, R., Carracedo, J., Nogueras, S., Buendia, P., Merino, A., Cañadillas, S., Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogénesis (2009) J Mol Cell Cardiol, 47, pp. 781-788
• Tonks, N.K., Neel, B.G., Combinatorial control of the specificity of protein tyrosine phosphatases (2001) Curr Opin Cell Biol, 13, pp. 182-195
• Vittori, D., Pregi, N., Pérez, G., Garbossa, G., Nesse, A., The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor (2005) Biochim Biophys Acta, 1743, pp. 29-36
• Walrafen, P., Verdier, V.F., Kadri, Z., Chrétien, S., Lacombe, C., Mayeux, P., Both proteasomes and lysosomes degrade the activated erythropoietin receptor (2005) Blood, 105, pp. 600-608
• Wenker, S.D., Chamorro, M.E., Vota, D.M., Callero, M.A., Vittori, D.C., Nesse, A.B., Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells (2010) J Cell Biochem, 110, pp. 151-161
• Xu, X., Cao, Z., Cao, B., Li, J., Guo, L., Que, L., Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism (2009) Surgery, 146, pp. 5-14

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------